EU Adaptive Pathways and Clinical Development
EU Adaptive Pathways and Clinical Development Understanding Adaptive Pathways in EU Clinical Development The European Union (EU) has increasingly embraced adaptive pathways as a regulatory and clinical trial strategy to accelerate patient access to innovative therapies, particularly in areas of high unmet medical need such as oncology, rare diseases, and advanced therapies. Adaptive pathways—sometimes referred…